Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9924519 | 0.82 | LMNA (0.37) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL130762 | 0.80 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL21284569 | 0.80 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL17067673 | 0.80 | CYP4F2 (0.37) | CYP4F2CYP4A11LMNAHSD17B10KDM4E | |
| SCHEMBL11991310 | 0.80 | LMNA (0.33) | CYP4F2CYP4A11LMNAHSD17B10 | |
| SCHEMBL6368436 | 0.78 | CYP4F2 (0.37) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL13301441 | 0.78 | CYP4F2 (0.37) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL1628655 | 0.78 | CYP4F2 (0.44) | CYP4F2CYP4A11LMNAHSD17B10KDM4E | |
| SCHEMBL2179864 | 0.78 | CYP4F2 (0.39) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL10094796 | 0.77 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150752-B2 | Coating composition with trisamine functionalized dispersant | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20150252213-A1 | COATING COMPOSITION WITH TRISAMINE FUNCTIONALIZED DISPERSANT | DOW GLOBAL TECHNOLOGIES LLC | 2015-09-10 | — | — | US | disclosed |
| US-20130195954-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130195954-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2013-08-01 | — | — | US | disclosed |
| US-8338492-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-25 | — | — | US | disclosed |
| US-8334324-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-12-18 | — | — | US | disclosed |
| US-20120107365-A1 | FILMS AND PARTICLES | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110152305-A1 | FILMS AND PARTICLES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-7671095-B2 | Films and particles | THE TRUSTEES OF THE BOSTON UNIVERSITY (US) | 2010-03-02 | — | — | US | disclosed |
| US-20080075718-A1 | Films and Particles | THE TRUSTEES OF THE BOSTON UNIVERSITY | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152305-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | CYP4F2 3742/4885CYP4A11 3623/4885LMNA 220/4885 |
| US-20130195954-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | CYP4F2 3742/4885CYP4A11 3623/4885LMNA 220/4885 |
| US-20080075718-A1 | Films and Particles | APOB, PGF, ACTB | CYP4F2 3742/4885CYP4A11 3623/4885LMNA 220/4885 |
| US-20120107365-A1 | FILMS AND PARTICLES | APOB, PGF, ACTB | CYP4F2 3742/4885CYP4A11 3623/4885LMNA 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.